APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical CRO Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026194 pages

Choose your research edition.

Industry ResearchPharmaceutical CRO Services Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical CRO Services Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pharmaceutical CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical CRO Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical CRO Services Market Analysis and Forecast 2026-2032258 pages · $4,950 USD

Market perspective

The global Pharmaceutical CRO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical CRO Services include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health and Charles River Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical CRO Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical CRO Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical CRO Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical CRO Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical CRO Services Segment by Company

PPD (Thermo Fisher)

Space Peptides

Aurigene Pharmaceutical Services

IQVIA

Labcorp Drug Development

Parexel

ICON plc

Syneos Health

Charles River Laboratories

Medpace

SGS SA

KCR CRO

TFS HealthScience

Caidya

Worldwide Clinical Trials

CTI

Advanced Clinical

WuXi AppTec

Pharmaron Inc.

Hangzhou Tigermed Consulting

JOINN Laboratories

MEDICILON

Pharmaceutical CRO Services Segment by Type

Preclinical CRO

Clinical Trial CRO

Pharmaceutical CRO Services Segment by Application

Commercial

Scientific Research

Other

Pharmaceutical CRO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical CRO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical CRO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical CRO Services industry.

Chapter 3: Detailed analysis of Pharmaceutical CRO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CRO Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical CRO Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Preclinical CRO Table 3. Key Players of Clinical Trial CRO Table 4. Global Pharmaceutical CRO Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Commercial Table 6. Key Players of Scientific Research Table 7. Key Players of Other Table 8. Global Pharmaceutical CRO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharmaceutical CRO Services Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical CRO Services Market Share by Region (2021-2026) Table 11. Global Pharmaceutical CRO Services Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical CRO Services Market Share by Region (2027-2032) Table 13. Pharmaceutical CRO Services Industry Trends Table 14. Pharmaceutical CRO Services Industry Drivers Table 15. Pharmaceutical CRO Services Industry Opportunities and Challenges Table 16. Pharmaceutical CRO Services Industry Restraints Table 17. Global Pharmaceutical CRO Services Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharmaceutical CRO Services Revenue Market Share by Company (2021-2026) Table 19. Global Pharmaceutical CRO Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmaceutical CRO Services Key Company Head Office and Area Served Table 21. Global Pharmaceutical CRO Services Company, Product Type & Application Table 22. Global Pharmaceutical CRO Services Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmaceutical CRO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharmaceutical CRO Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical CRO Services Revenue Market Share by Type (2021-2026) Table 29. Global Pharmaceutical CRO Services Revenue Market Share by Type (2027-2032) Table 30. Global Pharmaceutical CRO Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical CRO Services Revenue Market Share by Application (2021-2026) Table 34. Global Pharmaceutical CRO Services Revenue Market Share by Application (2027-2032) Table 35. PPD (Thermo Fisher) Company Information Table 36. PPD (Thermo Fisher) Business Overview Table 37. PPD (Thermo Fisher) Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. PPD (Thermo Fisher) Pharmaceutical CRO Services Product Portfolio Table 39. PPD (Thermo Fisher) Recent Development Table 40. Space Peptides Company Information Table 41. Space Peptides Business Overview Table 42. Space Peptides Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Space Peptides Pharmaceutical CRO Services Product Portfolio Table 44. Space Peptides Recent Development Table 45. Aurigene Pharmaceutical Services Company Information Table 46. Aurigene Pharmaceutical Services Business Overview Table 47. Aurigene Pharmaceutical Services Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Aurigene Pharmaceutical Services Pharmaceutical CRO Services Product Portfolio Table 49. Aurigene Pharmaceutical Services Recent Development Table 50. IQVIA Company Information Table 51. IQVIA Business Overview Table 52. IQVIA Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. IQVIA Pharmaceutical CRO Services Product Portfolio Table 54. IQVIA Recent Development Table 55. Labcorp Drug Development Company Information Table 56. Labcorp Drug Development Business Overview Table 57. Labcorp Drug Development Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Labcorp Drug Development Pharmaceutical CRO Services Product Portfolio Table 59. Labcorp Drug Development Recent Development Table 60. Parexel Company Information Table 61. Parexel Business Overview Table 62. Parexel Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Parexel Pharmaceutical CRO Services Product Portfolio Table 64. Parexel Recent Development Table 65. ICON plc Company Information Table 66. ICON plc Business Overview Table 67. ICON plc Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. ICON plc Pharmaceutical CRO Services Product Portfolio Table 69. ICON plc Recent Development Table 70. Syneos Health Company Information Table 71. Syneos Health Business Overview Table 72. Syneos Health Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Syneos Health Pharmaceutical CRO Services Product Portfolio Table 74. Syneos Health Recent Development Table 75. Charles River Laboratories Company Information Table 76. Charles River Laboratories Business Overview Table 77. Charles River Laboratories Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Charles River Laboratories Pharmaceutical CRO Services Product Portfolio Table 79. Charles River Laboratories Recent Development Table 80. Medpace Company Information Table 81. Medpace Business Overview Table 82. Medpace Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Medpace Pharmaceutical CRO Services Product Portfolio Table 84. Medpace Recent Development Table 85. SGS SA Company Information Table 86. SGS SA Business Overview Table 87. SGS SA Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. SGS SA Pharmaceutical CRO Services Product Portfolio Table 89. SGS SA Recent Development Table 90. KCR CRO Company Information Table 91. KCR CRO Business Overview Table 92. KCR CRO Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. KCR CRO Pharmaceutical CRO Services Product Portfolio Table 94. KCR CRO Recent Development Table 95. TFS HealthScience Company Information Table 96. TFS HealthScience Business Overview Table 97. TFS HealthScience Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. TFS HealthScience Pharmaceutical CRO Services Product Portfolio Table 99. TFS HealthScience Recent Development Table 100. Caidya Company Information Table 101. Caidya Business Overview Table 102. Caidya Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Caidya Pharmaceutical CRO Services Product Portfolio Table 104. Caidya Recent Development Table 105. Worldwide Clinical Trials Company Information Table 106. Worldwide Clinical Trials Business Overview Table 107. Worldwide Clinical Trials Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Worldwide Clinical Trials Pharmaceutical CRO Services Product Portfolio Table 109. Worldwide Clinical Trials Recent Development Table 110. CTI Company Information Table 111. CTI Business Overview Table 112. CTI Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. CTI Pharmaceutical CRO Services Product Portfolio Table 114. CTI Recent Development Table 115. Advanced Clinical Company Information Table 116. Advanced Clinical Business Overview Table 117. Advanced Clinical Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Advanced Clinical Pharmaceutical CRO Services Product Portfolio Table 119. Advanced Clinical Recent Development Table 120. WuXi AppTec Company Information Table 121. WuXi AppTec Business Overview Table 122. WuXi AppTec Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. WuXi AppTec Pharmaceutical CRO Services Product Portfolio Table 124. WuXi AppTec Recent Development Table 125. Pharmaron Inc. Company Information Table 126. Pharmaron Inc. Business Overview Table 127. Pharmaron Inc. Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Pharmaron Inc. Pharmaceutical CRO Services Product Portfolio Table 129. Pharmaron Inc. Recent Development Table 130. Hangzhou Tigermed Consulting Company Information Table 131. Hangzhou Tigermed Consulting Business Overview Table 132. Hangzhou Tigermed Consulting Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Hangzhou Tigermed Consulting Pharmaceutical CRO Services Product Portfolio Table 134. Hangzhou Tigermed Consulting Recent Development Table 135. JOINN Laboratories Company Information Table 136. JOINN Laboratories Business Overview Table 137. JOINN Laboratories Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. JOINN Laboratories Pharmaceutical CRO Services Product Portfolio Table 139. JOINN Laboratories Recent Development Table 140. MEDICILON Company Information Table 141. MEDICILON Business Overview Table 142. MEDICILON Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. MEDICILON Pharmaceutical CRO Services Product Portfolio Table 144. MEDICILON Recent Development Table 145. North America Pharmaceutical CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 146. North America Pharmaceutical CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 147. North America Pharmaceutical CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 148. North America Pharmaceutical CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 149. North America Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Pharmaceutical CRO Services Market Size by Country (2021-2026) Table 151. North America Pharmaceutical CRO Services Market Size by Country (2027-2032) Table 152. Europe Pharmaceutical CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 153. Europe Pharmaceutical CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 154. Europe Pharmaceutical CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 155. Europe Pharmaceutical CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 156. Europe Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Pharmaceutical CRO Services Market Size by Country (2021-2026) Table 158. Europe Pharmaceutical CRO Services Market Size by Country (2027-2032) Table 159. China Pharmaceutical CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 160. China Pharmaceutical CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 161. China Pharmaceutical CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 162. China Pharmaceutical CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 163. Asia Pharmaceutical CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 164. Asia Pharmaceutical CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 165. Asia Pharmaceutical CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 166. Asia Pharmaceutical CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 167. Asia Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Asia Pharmaceutical CRO Services Market Size by Country (2021-2026) Table 169. Asia Pharmaceutical CRO Services Market Size by Country (2027-2032) Table 170. South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 171. South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 172. South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 173. South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 174. South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2021-2026) Table 176. South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2027-2032) Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Pharmaceutical CRO Services Product Image Figure 2. Global Pharmaceutical CRO Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical CRO Services Market Share by Type: 2025 VS 2032 Figure 4. Preclinical CRO Image Figure 5. Clinical Trial CRO Image Figure 6. Global Pharmaceutical CRO Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Pharmaceutical CRO Services Market Share by Application: 2025 VS 2032 Figure 8. Commercial Image Figure 9. Scientific Research Image Figure 10. Other Image Figure 11. Global Pharmaceutical CRO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 13. Global Pharmaceutical CRO Services Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Pharmaceutical CRO Services Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Pharmaceutical CRO Services Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pharmaceutical CRO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical CRO Services Revenue Market Share by Type (2021-2032) Figure 20. Global Pharmaceutical CRO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical CRO Services Revenue Market Share by Application (2021-2032) Figure 22. North America Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical CRO Services Market Share by Type (2021-2032) Figure 24. North America Pharmaceutical CRO Services Market Share by Application (2021-2032) Figure 25. North America Pharmaceutical CRO Services Market Share by Country (2021-2032) Figure 26. United States Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 27. Canada Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 29. Europe Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 30. Europe Pharmaceutical CRO Services Market Share by Type (2021-2032) Figure 31. Europe Pharmaceutical CRO Services Market Share by Application (2021-2032) Figure 32. Europe Pharmaceutical CRO Services Market Share by Country (2021-2032) Figure 33. Germany Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 34. France Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 36. Italy Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 37. Russia Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 39. China Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 40. China Pharmaceutical CRO Services Market Share by Type (2021-2032) Figure 41. China Pharmaceutical CRO Services Market Share by Application (2021-2032) Figure 42. Asia Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 43. Asia Pharmaceutical CRO Services Market Share by Type (2021-2032) Figure 44. Asia Pharmaceutical CRO Services Market Share by Application (2021-2032) Figure 45. Asia Pharmaceutical CRO Services Market Share by Country (2021-2032) Figure 46. Japan Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 50. India Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 51. Australia Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Pharmaceutical CRO Services Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Pharmaceutical CRO Services Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Pharmaceutical CRO Services Market Share by Country (2021-2032) Figure 56. Brazil Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 61. UAE Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 63. Chile Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical Trial CRO
Applications
  • Commercial
  • Scientific Research
  • Other
Companies covered
  • PPD (Thermo Fisher)
  • Space Peptides
  • Aurigene Pharmaceutical Services
  • IQVIA
  • Labcorp Drug Development
  • Parexel
  • ICON plc
  • Syneos Health
  • Charles River Laboratories
  • Medpace
  • SGS SA
  • KCR CRO
  • TFS HealthScience
  • Caidya
  • Worldwide Clinical Trials
  • CTI
  • Advanced Clinical
  • WuXi AppTec
  • Pharmaron Inc.
  • Hangzhou Tigermed Consulting
  • JOINN Laboratories
  • MEDICILON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical CRO Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Preclinical CRO
  5. 1.2.3 Clinical Trial CRO
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Pharmaceutical CRO Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Commercial
  9. 1.3.3 Scientific Research
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Pharmaceutical CRO Services Growth Trends by Region
  13. 1.5.1 Global Pharmaceutical CRO Services Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Pharmaceutical CRO Services Market Size by Region (2021-2026)
  15. 1.5.3 Pharmaceutical CRO Services Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Pharmaceutical CRO Services Market Dynamics
  1. 2.1 Pharmaceutical CRO Services Industry Trends
  2. 2.2 Pharmaceutical CRO Services Industry Drivers
  3. 2.3 Pharmaceutical CRO Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical CRO Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical CRO Services Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical CRO Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical CRO Services Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical CRO Services Company, Product Type & Application
  5. 3.5 Global Pharmaceutical CRO Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical CRO Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical CRO Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical CRO Services Tier 1, Tier 2, and Tier 3
4 Pharmaceutical CRO Services Market by Type
  1. 4.1 Global Pharmaceutical CRO Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical CRO Services Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical CRO Services Market Size Share by Type (2021-2032)
5 Pharmaceutical CRO Services Market by Application
  1. 5.1 Global Pharmaceutical CRO Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical CRO Services Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical CRO Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 PPD (Thermo Fisher)
  2. 6.1.1 PPD (Thermo Fisher) Company Information
  3. 6.1.2 PPD (Thermo Fisher) Business Overview
  4. 6.1.3 PPD (Thermo Fisher) Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 PPD (Thermo Fisher) Pharmaceutical CRO Services Product Portfolio
  6. 6.1.5 PPD (Thermo Fisher) Recent Developments
  7. 6.2 Space Peptides
  8. 6.2.1 Space Peptides Company Information
  9. 6.2.2 Space Peptides Business Overview
  10. 6.2.3 Space Peptides Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Space Peptides Pharmaceutical CRO Services Product Portfolio
  12. 6.2.5 Space Peptides Recent Developments
  13. 6.3 Aurigene Pharmaceutical Services
  14. 6.3.1 Aurigene Pharmaceutical Services Company Information
  15. 6.3.2 Aurigene Pharmaceutical Services Business Overview
  16. 6.3.3 Aurigene Pharmaceutical Services Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Aurigene Pharmaceutical Services Pharmaceutical CRO Services Product Portfolio
  18. 6.3.5 Aurigene Pharmaceutical Services Recent Developments
  19. 6.4 IQVIA
  20. 6.4.1 IQVIA Company Information
  21. 6.4.2 IQVIA Business Overview
  22. 6.4.3 IQVIA Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 IQVIA Pharmaceutical CRO Services Product Portfolio
  24. 6.4.5 IQVIA Recent Developments
  25. 6.5 Labcorp Drug Development
  26. 6.5.1 Labcorp Drug Development Company Information
  27. 6.5.2 Labcorp Drug Development Business Overview
  28. 6.5.3 Labcorp Drug Development Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Labcorp Drug Development Pharmaceutical CRO Services Product Portfolio
  30. 6.5.5 Labcorp Drug Development Recent Developments
  31. 6.6 Parexel
  32. 6.6.1 Parexel Company Information
  33. 6.6.2 Parexel Business Overview
  34. 6.6.3 Parexel Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Parexel Pharmaceutical CRO Services Product Portfolio
  36. 6.6.5 Parexel Recent Developments
  37. 6.7 ICON plc
  38. 6.7.1 ICON plc Company Information
  39. 6.7.2 ICON plc Business Overview
  40. 6.7.3 ICON plc Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ICON plc Pharmaceutical CRO Services Product Portfolio
  42. 6.7.5 ICON plc Recent Developments
  43. 6.8 Syneos Health
  44. 6.8.1 Syneos Health Company Information
  45. 6.8.2 Syneos Health Business Overview
  46. 6.8.3 Syneos Health Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Syneos Health Pharmaceutical CRO Services Product Portfolio
  48. 6.8.5 Syneos Health Recent Developments
  49. 6.9 Charles River Laboratories
  50. 6.9.1 Charles River Laboratories Company Information
  51. 6.9.2 Charles River Laboratories Business Overview
  52. 6.9.3 Charles River Laboratories Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Charles River Laboratories Pharmaceutical CRO Services Product Portfolio
  54. 6.9.5 Charles River Laboratories Recent Developments
  55. 6.10 Medpace
  56. 6.10.1 Medpace Company Information
  57. 6.10.2 Medpace Business Overview
  58. 6.10.3 Medpace Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Medpace Pharmaceutical CRO Services Product Portfolio
  60. 6.10.5 Medpace Recent Developments
  61. 6.11 SGS SA
  62. 6.11.1 SGS SA Company Information
  63. 6.11.2 SGS SA Business Overview
  64. 6.11.3 SGS SA Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 SGS SA Pharmaceutical CRO Services Product Portfolio
  66. 6.11.5 SGS SA Recent Developments
  67. 6.12 KCR CRO
  68. 6.12.1 KCR CRO Company Information
  69. 6.12.2 KCR CRO Business Overview
  70. 6.12.3 KCR CRO Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 KCR CRO Pharmaceutical CRO Services Product Portfolio
  72. 6.12.5 KCR CRO Recent Developments
  73. 6.13 TFS HealthScience
  74. 6.13.1 TFS HealthScience Company Information
  75. 6.13.2 TFS HealthScience Business Overview
  76. 6.13.3 TFS HealthScience Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 TFS HealthScience Pharmaceutical CRO Services Product Portfolio
  78. 6.13.5 TFS HealthScience Recent Developments
  79. 6.14 Caidya
  80. 6.14.1 Caidya Company Information
  81. 6.14.2 Caidya Business Overview
  82. 6.14.3 Caidya Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Caidya Pharmaceutical CRO Services Product Portfolio
  84. 6.14.5 Caidya Recent Developments
  85. 6.15 Worldwide Clinical Trials
  86. 6.15.1 Worldwide Clinical Trials Company Information
  87. 6.15.2 Worldwide Clinical Trials Business Overview
  88. 6.15.3 Worldwide Clinical Trials Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Worldwide Clinical Trials Pharmaceutical CRO Services Product Portfolio
  90. 6.15.5 Worldwide Clinical Trials Recent Developments
  91. 6.16 CTI
  92. 6.16.1 CTI Company Information
  93. 6.16.2 CTI Business Overview
  94. 6.16.3 CTI Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 CTI Pharmaceutical CRO Services Product Portfolio
  96. 6.16.5 CTI Recent Developments
  97. 6.17 Advanced Clinical
  98. 6.17.1 Advanced Clinical Company Information
  99. 6.17.2 Advanced Clinical Business Overview
  100. 6.17.3 Advanced Clinical Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Advanced Clinical Pharmaceutical CRO Services Product Portfolio
  102. 6.17.5 Advanced Clinical Recent Developments
  103. 6.18 WuXi AppTec
  104. 6.18.1 WuXi AppTec Company Information
  105. 6.18.2 WuXi AppTec Business Overview
  106. 6.18.3 WuXi AppTec Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 WuXi AppTec Pharmaceutical CRO Services Product Portfolio
  108. 6.18.5 WuXi AppTec Recent Developments
  109. 6.19 Pharmaron Inc.
  110. 6.19.1 Pharmaron Inc. Company Information
  111. 6.19.2 Pharmaron Inc. Business Overview
  112. 6.19.3 Pharmaron Inc. Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Pharmaron Inc. Pharmaceutical CRO Services Product Portfolio
  114. 6.19.5 Pharmaron Inc. Recent Developments
  115. 6.20 Hangzhou Tigermed Consulting
  116. 6.20.1 Hangzhou Tigermed Consulting Company Information
  117. 6.20.2 Hangzhou Tigermed Consulting Business Overview
  118. 6.20.3 Hangzhou Tigermed Consulting Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Hangzhou Tigermed Consulting Pharmaceutical CRO Services Product Portfolio
  120. 6.20.5 Hangzhou Tigermed Consulting Recent Developments
  121. 6.21 JOINN Laboratories
  122. 6.21.1 JOINN Laboratories Company Information
  123. 6.21.2 JOINN Laboratories Business Overview
  124. 6.21.3 JOINN Laboratories Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 JOINN Laboratories Pharmaceutical CRO Services Product Portfolio
  126. 6.21.5 JOINN Laboratories Recent Developments
  127. 6.22 MEDICILON
  128. 6.22.1 MEDICILON Company Information
  129. 6.22.2 MEDICILON Business Overview
  130. 6.22.3 MEDICILON Pharmaceutical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 MEDICILON Pharmaceutical CRO Services Product Portfolio
  132. 6.22.5 MEDICILON Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical CRO Services Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical CRO Services Market Size by Type
  3. 7.2.1 North America Pharmaceutical CRO Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical CRO Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical CRO Services Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical CRO Services Market Size by Application
  7. 7.3.1 North America Pharmaceutical CRO Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical CRO Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical CRO Services Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical CRO Services Market Size by Country
  11. 7.4.1 North America Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical CRO Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical CRO Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical CRO Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical CRO Services Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical CRO Services Market Size by Type
  3. 8.2.1 Europe Pharmaceutical CRO Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical CRO Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical CRO Services Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical CRO Services Market Size by Application
  7. 8.3.1 Europe Pharmaceutical CRO Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical CRO Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical CRO Services Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical CRO Services Market Size by Country
  11. 8.4.1 Europe Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical CRO Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical CRO Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical CRO Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical CRO Services Market Size (2021-2032)
  2. 9.2 China Pharmaceutical CRO Services Market Size by Type
  3. 9.2.1 China Pharmaceutical CRO Services Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical CRO Services Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical CRO Services Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical CRO Services Market Size by Application
  7. 9.3.1 China Pharmaceutical CRO Services Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical CRO Services Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical CRO Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical CRO Services Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical CRO Services Market Size by Type
  3. 10.2.1 Asia Pharmaceutical CRO Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical CRO Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical CRO Services Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical CRO Services Market Size by Application
  7. 10.3.1 Asia Pharmaceutical CRO Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical CRO Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical CRO Services Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical CRO Services Market Size by Country
  11. 10.4.1 Asia Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical CRO Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical CRO Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical CRO Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical CRO Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical CRO Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical CRO Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical CRO Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst